IL6 and left ventricular hypertrophy: We did not find significant differences between the two patient cohorts with respect to gender, body mass index, anthropometric parameters, the presence of dyslipidemia, hypertension, stable coronary artery disease, smoking, abdominal obesity, left ventricular hypertrophy, New York Heart Association classes, systolic and diastolic blood pressure, left ventricular end-diastolic and end-systolic volumes, LVEF, LVMMI, E/e`, GLS, eGFR, lipid profile, glucose levels, HOMA-IR, HbA1c, and concentrations of TNF-alpha, galectin-3, IL-6, and hs-TrT.